Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziming Li

Showing results (61-70 of 224) with videos related to

Pageof 23
Sort By:
Lung Cancer (Amsterdam, Netherlands)|September 18, 2022
Proposal for multiple new lesions as complement of hyperprogressive disease in NSCLC patients treated with PD-1/PD-L1 immunotherapyMengxiao Wang, Huayan Huang, Zhangwendi Xu, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2025
DTCFinder: a bench-to-bits toolkit for label-free, whole-spectrum analysis of disseminated and circulating tumor cells in liquid biopsiesXiaowei Yan, Zhuo Wang, Ziming Li, et al.
Frontiers in Immunology|February 12, 2024
ADGRE5-centered Tsurv model in T cells recognizes responders to neoadjuvant cancer immunotherapyJian Li, Zhouwenli Meng, Zhengqi Cao, et al.
Cell Death Discovery|June 2, 2026
MYBL2 impedes cisplatin sensitivity through suppressing GSDME-mediated pyroptosis in lung adenocarcinomaTingting Lu, Jie Zhang, Wendi Xuzhang, et al.
Oncology Letters|February 7, 2025
Comparative efficacy and safety of first‑line PD‑1/PD‑L1 inhibitors in immunotherapy for non‑small cell lung cancer: A network meta‑analysisLiyan Liu, Yilong Yan, Yuqiao Wang, et al.
Oncogene|September 8, 2020
Correction: FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancerKaixuan Wang, Wenxiang Ji, Yongfeng Yu, et al.
Translational Lung Cancer Research|March 14, 2022
The relationship between different subtypes of <i>KRAS</i> and PD-L1 & tumor mutation burden (TMB) based on next-generation sequencing (NGS) detection in Chinese lung cancer patientsYing Yang, Shengping Shen, Yingjia Sun, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 23, 2018
SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4Ziming Li, Jia Huang, Shengping Shen, et al.
Cell Biochemistry and Function|June 3, 2010
Functional roles of PC-PLC and Cdc20 in the cell cycle, proliferation, and apoptosisZhiwei Chen, Yongfeng Yu, Da Fu, et al.
Plos One|April 25, 2013
Polymorphisms of microRNA sequences or binding sites and lung cancer: a meta-analysis and systematic reviewZhiwei Chen, Ling Xu, Xiangyun Ye, et al.
Pageof 23

Showing results (61-70 of 224) with videos related to

Sort By:
Pageof 23
Lung Cancer (Amsterdam, Netherlands)|September 18, 2022
Proposal for multiple new lesions as complement of hyperprogressive disease in NSCLC patients treated with PD-1/PD-L1 immunotherapyMengxiao Wang, Huayan Huang, Zhangwendi Xu, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2025
DTCFinder: a bench-to-bits toolkit for label-free, whole-spectrum analysis of disseminated and circulating tumor cells in liquid biopsiesXiaowei Yan, Zhuo Wang, Ziming Li, et al.
Frontiers in Immunology|February 12, 2024
ADGRE5-centered Tsurv model in T cells recognizes responders to neoadjuvant cancer immunotherapyJian Li, Zhouwenli Meng, Zhengqi Cao, et al.
Cell Death Discovery|June 2, 2026
MYBL2 impedes cisplatin sensitivity through suppressing GSDME-mediated pyroptosis in lung adenocarcinomaTingting Lu, Jie Zhang, Wendi Xuzhang, et al.
Oncology Letters|February 7, 2025
Comparative efficacy and safety of first‑line PD‑1/PD‑L1 inhibitors in immunotherapy for non‑small cell lung cancer: A network meta‑analysisLiyan Liu, Yilong Yan, Yuqiao Wang, et al.
Oncogene|September 8, 2020
Correction: FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancerKaixuan Wang, Wenxiang Ji, Yongfeng Yu, et al.
Translational Lung Cancer Research|March 14, 2022
The relationship between different subtypes of <i>KRAS</i> and PD-L1 & tumor mutation burden (TMB) based on next-generation sequencing (NGS) detection in Chinese lung cancer patientsYing Yang, Shengping Shen, Yingjia Sun, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 23, 2018
SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4Ziming Li, Jia Huang, Shengping Shen, et al.
Cell Biochemistry and Function|June 3, 2010
Functional roles of PC-PLC and Cdc20 in the cell cycle, proliferation, and apoptosisZhiwei Chen, Yongfeng Yu, Da Fu, et al.
Plos One|April 25, 2013
Polymorphisms of microRNA sequences or binding sites and lung cancer: a meta-analysis and systematic reviewZhiwei Chen, Ling Xu, Xiangyun Ye, et al.
Pageof 23